Hologic, Inc.

Hologic, Inc. develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical devices focused on women's health, operating across the United States, Europe, Asia-Pacific and globally.

The company is organized into four key segments:

• Diagnostics:

  • Aptima Molecular Assays for detecting infectious microorganisms

  • Viral Load Tests: HIV, Hepatitis B & C

  • SARS-CoV-2 Detection: Aptima and Panther Fusion COVID-19 assays

  • ThinPrep System for cytology applications

  • Rapid Fetal Fibronectin Test for preterm birth risk assessment

  • Group B Streptococcus diagnostic tests

• Breast Health:

  • 2D and 3D digital mammography systems and reading workstations

  • Minimally invasive biopsy systems, site markers and localization tools

  • Specimen radiology, breast-conserving surgery products

  • Ultrasound and connectivity solutions

• GYN Surgical:

  • NovaSure Endometrial Ablation System for abnormal uterine bleeding

  • MyoSure Hysteroscopic Tissue Removal System for fibroids, polyps, and uterine pathology

  • Fluent Fluid Management System for hysteroscopic procedures

• Skeletal Health:

  • Horizon DXA System for bone density testing

  • Fluoroscan Insight FD Mini C-Arm for minimally invasive orthopedic procedures

Hologic sells its products via direct sales teams and a network of independent distributors and sales representatives.

Founded in 1985, Hologic is headquartered in Marlborough, Massachusetts.